Bayer CropScience Ltd
Bayer CropScience Q2 FY20 earnings call: Revenue & Margins
Q2 FY20 investor presentation: what the company reported on revenue, margins and projects.
Based on Bayer CropScience Ltd's Q2 FY20 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20). EBITDA for Q3 2019: €1,492 million, up 9.3% year-on-year (YoY) - Operating margin: 21.8%, up 51 basis points YoY - Profit (PAT) for Q3 2019: €1,010 million, up 41.7% YoY - No explicit margin outlook is stated in the presentation.
From Bayer CropScience Ltd's Q2 FY20 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20).
- H1 Revenue from Operations: ₹22,967 million, +7.3% year-on-year growth (Page 20).
- Q2 Profit Before Exceptional Items and Tax: ₹4,978 million, +1.3% year-on-year (Page 20).
- H1 Profit Before Exceptional Items and Tax: ₹4,913 million, +22.2% year-on-year (Page 20).
- Sept YTD EverGol Xtend & Velum Prime sales: 17 KL with a full-year estimate of 23 KL (Page 24).
- Arize business milestone: volume achieved 15,570 MT (Page 23).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Bayer CropScience Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bayer CropScience Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Aries Agro Ltd (Q2 FY20)
EBITDA: INR 450 million (H1-FY20) with margin 16.96% (FY19 full year). Key concall takeaways from Aries Agro Ltd's Q2 FY20 earnings call — and how it ranks…
Frequently Asked Questions
What were Bayer CropScience Ltd Q2 FY20 results?
Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20). EBITDA for Q3 2019: €1,492 million, up 9.3% year-on-year (YoY) - Operating margin: 21.8%, up 51 basis points YoY - Profit (PAT) for Q3 2019: €1,010 million, up 41.7% YoY - No explicit margin outlook is stated in the presentation.
What is Bayer CropScience Ltd share price analysis?
Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.
Is Bayer CropScience Ltd planning capital expenditure?
The presentation does not explicitly describe any capex, capacity expansion, or new plant/project details, amounts, status, or timelines.
Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.